As the pandemic developed, many doctors treated patients early with hydroxychloroquine, seemingly all with success.
As a result there are very many doctors’ statements to be found, to the effect that early treatment for Covid-19 with HCQ is both effective and necessary.
Or that antiviral x, y or z is effective for covid when given early.
Or “We have treated (a large number) of patients with (a small number) of deaths”
(often followed by “We have been banned from social media”).
Below is a sample of statements by doctors on early Covid-19 treatment, with emphasis on hydroxychloroquine.
|—————————————————————————————————————————————————-|
“Most COVID-19-associated deaths are preventable with early detection and outpatient treatment”
Professor Matthieu Million
|—————————————————————————————————————————————————-|
“The results are excellent! I can say this with certainty because I have the data not only from my own patients but also from other colleagues. To date, we have far exceeded 6,000 cases treated. Of these, only a small percentage has required hospital treatment for a short time, but these are the people who came to us late. Our experience shows that early intervention is the winning strategy. The mortality rate of the patients we treat is practically zero: among those we have treated within a week of the onset of symptoms, we have had no deaths.”
https://www.lifesitenews.com/news/italian-doctors-association-is-successfully-treating-covid-at-home-with-hcq-and-vitamin-d/
Dr. Paolo Martino Allegri, co-founder of IppocrateOrg, 23 Mar 21.
|—————————————————————————————————————————————————-|
Dr George Fareed and Dr Brian Tyson story banned by Twitter and YouTube
(Never heard of them? Here’s why:
Covid success story banned by Twitter and YouTube, 21 Jan 22.
Drs. George Fareed of Brawley, Brian Tyson of El Centro treated 7,000 patients)
|—————————————————————————————————————————————————-|
“Early treatment is key,” explained Dr. Brian Tyson. It doesn’t matter how old people are. If we treat them early on, their condition will improve, he said.
|—————————————————————————————————————————————————-|
“US cumulative deaths through July 15 are 140,000. Had we permitted HCQ use liberally, we would have saved half, 70,000 and it is very possible we could have saved 3/4, 105,000.”
Dr Harvey Risch: Interview with Dr Simone Gold, July 15, 2020, also to Laura Ingraham July 20, 2020.
|—————————————————————————————————————————————————-|
“I think, actually, a suppression of early treatment was by design a vaccine promotion strategy”. Cardiologist Dr. Peter McCullough
|—————————————————————————————————————————————————-|
Dr. Ramin Oskui, CEO, Foxhall Cardiology:
“We used this drug in pregnant women. We used it in children. We use it without monitoring in countries for malaria prophylaxis”. 24 Apr 2020
|—————————————————————————————————————————————————-|
“The people that are saying that it doesn’t work, they are lying.” Dr Stella Immanuel
|—————————————————————————————————————————————————-|
Coronavirus: How Turkey took control of Covid-19 emergency.
Chief doctor Nurettin Yiyit – whose art work is on the hospital walls – says it’s key to use hydroxychloroquine early. “Other countries are using this drug too late,” he says, “especially the United States. We only use it at the beginning. We have no hesitation about this drug. We believe it’s effective because we get the results.”
On a tour of the hospital, adding and subtracting protective layers as we go, he explains that Turkey’s approach is to “get ahead of the virus”, by treating early and treating aggressively. They use hydroxychloroquine and other drugs, along with blood plasma and oxygen in high concentrations. 29 May 2020
|—————————————————————————————————————————————————-|
Not using early treatment is a “horrible crime against humanity” Dr. George Fareed
|—————————————————————————————————————————————————-|
“A great effort has been paid to find drugs and treatments for hospitalized, severely ill patients. However, medications used for the domiciliary management of early symptoms, notwithstanding their importance, have not been and are not presently regarded with the same attention and seriousness.” Professor Piero Sestili 7 Oct, 2020
|—————————————————————————————————————————————————-|Gert Meeus, M.D. – Our paper of 4000 patients reporting favourable outcomes with hydroxychloroquine plus azithromycine for #COVID19 got rejected by the editor of four different journals, without allowing peer review. (April 2021 )
|—————————————————————————————————————————————————-|
CDC admissions that HCQ is a safe drug. These contrast with the long effort to suppress HCQ as an effective early treatment for Covid-19.
” Hydroxychloroquine is a relatively well tolerated medicine.”
“Hydroxychloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.”
From the CDC website; still showing as at 1 Sep, 2022, first stored on Thewaybackmachine 19/3/20.
Who can take hydroxychloroquine?
“Hydroxychloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.”
On page 2: ” Hydroxychloroquine is a relatively well tolerated medicine.”
|—————————————————————————————————————————————————-|
Professor Matthieu Million: “In the context of a pandemic with a lethal respiratory virus, we believe that early detection of positive cases and carefully controlled treatment with safe and well-tolerated drugs should be generalized in outpatient medicine, i.e. in individuals with mild symptoms before signs of severity appear.” June 2020
|—————————————————————————————————————————————————-|
From the paper of Dr Roland Derwand, Martin Scholz and Vladimir Zelenko, who treated thousands of Covid patients:
“As of June 2020, the diagnosis and treatment of COVID-19 have been almost exclusively studied from an inpatient perspective, including intensive care with mechanical ventilation. Only one study has described the characteristics and key health outcomes of COVID-19 diagnosed patients in an outpatient setting [3]. This is surprising as primary care physicians often see COVID-19 patients firs. Thus, they could play a critical role in early diagnosis, treatment and management of disease progression and virus spread. This assumption is supported by the established principle in medicine that speed of eradication is linked to the outcome of life-threatening infections [4]”.
“The early clinical phase of COVID-19 has not been the focus of much research so far, even though timing of antiviral treatment seems to be critical [5].
The optimal window for therapeutic intervention would seem to be before the infection spreads from the upper to lower respiratory tract and before severe inflammatory reaction ensues [6]”.
“Therefore, diagnosis and treatment of COVID-19 outpatients as early as possible, even based on clinical diagnosis only, may have been an underestimated first step to slow down or even stop the pandemic more effectively. “
“Based on clinical application principles of antiviral therapies, as demonstrated in the case of influenza A [7], antiviral treatments should be used early in the course of infection“.
Derwand et al. COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study, 28 Oct 2020,
Reference [5] from above: Goncalves et al. Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
|—————————————————————————————————————————————————-|
“I have treated over 100 patients without a single ER visit or need for hospitalization with advanced care. I am not alone in this. Other colleague have treated hundreds patients with the same success.” Dr Brian C Procter, July 2020
A video accompanying this Facebook post was removed by Youtube. By September, Procter and his colleagues had treated 320 moderate-high risk patients with one death, and his team wrote up their results in a study:
“The rates of death in our study indicate that early multidrug therapy is associated with > 90% reduction in mortality among the high risk compared to community rates of death associated with therapeutic nihilism in ambulatory patients who are subsequently hospitalized. The National Institutes of Health currently advise denial of early treatment and encourage late-stage hospitalization as the first window of treatment open to acutely ill patients with COVID-19 (COVID-19 Treatment Guidelines, 2020).
“Our contrary view, supported by our results, is that early ambulatory therapy should be offered as an emergency measure in acutely ill, high-risk COVID-19 as a strategy to reduce hospitalization and death”. Procter et al, Dec 2020. Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.
|—————————————————————————————————————————————————-|
“It is absolutely unacceptable that eighteen months into the pandemic we still haven’t come up with an early treatment approach. Instead there is a heavy reliance on a drive towards vaccinating as many people as possible which plays an important part in reducing hospital admissions, but it should not be the only strategy. Starting treatment at first symptom onset is the best opportunity to stop Covid-19 in its tracks and should play a central role in the management of Covid-19.” Dr Erika Drewes, 16 Oct 2021
|—————————————————————————————————————————————————-|
” It appears that the FDA, NIH, and cardiology society positions have been based upon theoretical calculations about potential adverse events and from measured physiological changes rather than on current real-world mortality experience with these medications and that their positions should be revised.” Prof. Harvey Risch, Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis (27 May 2020)
|—————————————————————————————————————————————————-|
It be absolutely amazing that…
this gunk means anything!
Page status: C